|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.85(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,005,861 |
52
Week Range: |
$38.26 - $88.63 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kroll Werner |
SVP, R&D |
|
2019-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,377 |
21,939 |
|
- |
|
Slacik Charles P |
Director |
|
2019-05-20 |
4 |
S |
$55.19 |
$55,190 |
D/D |
(1,000) |
8,703 |
|
- |
|
Buechler Kenneth F |
Director |
|
2019-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
745 |
50,433 |
|
- |
|
Slacik Charles P |
Director |
|
2019-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
222 |
9,703 |
|
- |
|
Buechler Kenneth F |
Director |
|
2019-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,919 |
49,688 |
|
- |
|
Schuler Jack W |
Director |
|
2019-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
3,101,149 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2019-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
20,950 |
|
- |
|
Michael Edward L |
Director |
|
2019-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
834 |
834 |
|
- |
|
Widder Kenneth J |
Director |
|
2019-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
12,316 |
|
- |
|
Slacik Charles P |
Director |
|
2019-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
9,481 |
|
- |
|
Strobeck Matthew |
Director |
|
2019-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
5,299 |
|
- |
|
Buechler Kenneth F |
Director |
|
2019-05-10 |
4 |
S |
$60.58 |
$121,286 |
D/D |
(2,002) |
47,769 |
|
- |
|
Buechler Kenneth F |
Director |
|
2019-05-10 |
4 |
OE |
$11.96 |
$23,944 |
D/D |
2,002 |
49,771 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2019-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,282 |
19,289 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2019-04-16 |
4 |
OE |
$15.73 |
$122,694 |
D/D |
7,800 |
17,007 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-03-29 |
4 |
S |
$65.70 |
$1,518,892 |
D/D |
(23,120) |
301,442 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-03-29 |
4 |
OE |
$12.63 |
$292,006 |
D/D |
23,120 |
324,562 |
|
- |
|
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2019-03-28 |
4 |
S |
$64.60 |
$839,742 |
D/D |
(13,000) |
9,598 |
|
- |
|
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2019-03-28 |
4 |
OE |
$15.40 |
$200,200 |
D/D |
13,000 |
22,598 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-03-28 |
4 |
S |
$65.06 |
$86,858 |
D/D |
(1,335) |
301,442 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-03-28 |
4 |
OE |
$12.63 |
$16,861 |
D/D |
1,335 |
302,777 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-03-27 |
4 |
S |
$65.03 |
$51,699 |
D/D |
(795) |
301,442 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-03-27 |
4 |
OE |
$12.63 |
$10,041 |
D/D |
795 |
302,237 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-03-14 |
4 |
S |
$68.00 |
$989,332 |
D/D |
(14,549) |
16,193 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-03-14 |
4 |
OE |
$15.40 |
$288,683 |
D/D |
14,549 |
30,445 |
|
- |
|
799 Records found
|
|
Page 13 of 32 |
|
|